Clinical Trial Update: A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex [Phase 1]

View source ↗

Summary

Phase I study evaluating the safety and pharmacokinetics of intravenous recombinant human CD4-immunoglobulin G (rCD4-IgG) in combination with oral zidovudine in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Aids-related Complex
• HIV Infection

Drugs mentioned

• Zidovudine (Zidovudine)
• recombinant human CD4-immunoglobulin G (rCD4-IgG) (recombinant human CD4-immunoglobulin G)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED